I support the removal of the requirement for physician information on controlled substance scripts for PAs. This restriction is a barrier to patient care and has led to limitations in patient access to medications and incorrect pharmacy restrictions on scripts that are not controlled substances, creating scenarios for risk of patient harm. The collaborating physician name/information provides no benefit on scripts, especially considering independent visits by the physician assistant in the first place.